Back
Keros Therapeutics, Inc. Vs. Aldeyra Therapeutics, Inc. Industry Stock Comparison
Buy
54
KROS
Keros Therapeutics, Inc.
Last Price:
$20.47
Seasonality Move:
4.91%
Buy
58
ALDX
Aldeyra Therapeutics, Inc.
Last Price:
$5.19
Seasonality Move:
10.5%
Buy
54
Keros Therapeutics, Inc. (KROS)
is a Buy
Is Keros Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Keros Therapeutics, Inc. [KROS] share price is $20.63. The Score for KROS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
KROS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Aldeyra Therapeutics, Inc. (ALDX)
is a Buy
Is Aldeyra Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Aldeyra Therapeutics, Inc. [ALDX] share price is $5.17. The Score for ALDX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
ALDX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KROS Stock Price Chart
What is Keros Therapeutics, Inc.'s stock price today?
-
The Keros Therapeutics, Inc. share price today is $20.63The current trend is moderately bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
ALDX Stock Price Chart
What is Aldeyra Therapeutics, Inc.'s stock price today?
-
The Aldeyra Therapeutics, Inc. share price today is $5.17The current trend is moderately bullish and ALDX is experiencing selling pressure, which indicates risk of future bearish movement.
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.89 | Buy |
| Relative Strength Index (14 RSI): | 57.05 | Buy |
| Chaikin Money Flow: | -192087 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.1 - 21.78) | Buy |
| Bollinger Bands (100): | (14.31 - 18.87) | Buy |
ALDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 51.95 | Buy |
| Chaikin Money Flow: | -232323 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.66 - 5.36) | Buy |
| Bollinger Bands (100): | (4.9 - 5.58) | Sell |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.87 | Sell |
| 20-day SMA: | 20.58 | Buy |
| 50-day SMA: | 17.94 | Buy |
| 200-day SMA: | 15 | Buy |
| 8-day EMA: | 20.95 | Sell |
| 20-day EMA: | 20.33 | Buy |
| 50-day EMA: | 18.66 | Buy |
| 200-day EMA: | 18.79 | Buy |
ALDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.23 | Sell |
| 20-day SMA: | 4.98 | Buy |
| 50-day SMA: | 5.06 | Buy |
| 200-day SMA: | 4.46 | Buy |
| 8-day EMA: | 5.15 | Buy |
| 20-day EMA: | 5.05 | Buy |
| 50-day EMA: | 5.06 | Buy |
| 200-day EMA: | 4.85 | Buy |
Keros Therapeutics, Inc. Earnings Growth & KROS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.45 per share, and a decrease next year of $5.27 per share.
Aldeyra Therapeutics, Inc. Earnings Growth & ALDX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $0.92 per share.
Keros Therapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aldeyra Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||